Opinion Author: Sidney Goldstein, MD Publish date: July 26, 2019
One overriding factor behind the slow uptake of Entresto for heart failure may be the cost of the drug compared to enalapril.
Opinion Author: Sidney Goldstein, MD Publish date: May 1, 2019
RCTs represent a very special subset of any disease process but they are the best we can do.
Opinion Author: Sidney Goldstein, MD Publish date: March 29, 2019
Community leadership has been minimized, and where it exists, it is under constant pressure to make a profit.
Opinion Author: Sidney Goldstein, MD Publish date: January 30, 2019
It’s up to physicians to build an ethical wall between interests in clinical research.
News Author: Sidney Goldstein, MD Publish date: December 4, 2018
Aspirin for the primary prevention of cardiovascular events is dead, so why does the CDC keep pushing it? <...
News Author: Sidney Goldstein, MD Publish date: October 29, 2018
Piero Anversa’s fraudulent research led to an NIH study in humans that is still ongoing.
Opinion Author: Sidney Goldstein, MD Publish date: May 25, 2018
Health care isn’t a commodity, and patients aren’t customers. We’re not talking about shoes.
News Author: Sidney Goldstein, MD Publish date: April 25, 2018
I recently received a letter from a former fellow who completed his training almost 25 years ago, thanking me for guiding him through his education...
News Author: Sidney Goldstein, MD Publish date: March 26, 2018
Or, don’t even try speaking directly your doctor.
Opinion Author: Sidney Goldstein, MD Publish date: January 29, 2018
Stick with beta-blocker therapy until evidence shows why not to use it.
Opinion Author: Sidney Goldstein, MD Publish date: January 2, 2018
Health agencies should take their cues from randomized clinical trial designs to avoid unintended consequences.
Article Author: Sidney Goldstein, MD Publish date: December 19, 2016
The recent report from the SYNTAX trials should give pause to our interventionalist colleagues embarking on multiple angioplasty and stenting proce...
Article Author: Sidney Goldstein, MD Publish date: October 26, 2016
TOPCAT is back again, having randomized its first patient with heart failure with preserved ejection fraction (HFpEF) almost 10 years ago for its t...
News Author: Sidney Goldstein, MD Publish date: September 30, 2016
News Author: Sidney Goldstein, MD Publish date: August 29, 2016
Progress in treating ischemic heart disease has resulted in more patients with heart failure, and we must work to develop more effective heart failure...
